PsyTech Tel Aviv

What is the PsyTech Summit?

PsyTech Summit is the global industry event for innovation in psychedelic medicine. With renewed research interest in LSD, MDMA, Ketamine and psilocybin, and a growing normalization after decades of stigma, psychedelics are quickly becoming the next therapeutic frontier.

Created by the team behind CannaTech, the PsyTech conference is poised to elevate the psychedelics conversation, foster normalization and accelerate innovation.

PsyTech debuts in Tel Aviv this June 14-15, 2020 and will bring together scientists, innovators, regulators, investors, and advocates from around the world to expand minds to the potential of psychedelic medicine.

Featured PsyTech Summit Speakers

BRUCE LINTON
Founder and Former Chairman & Co-CEO Canopy Growth Corporation
JR RAHN
Founder & Co-CEO Mindmed
KEREN TZARFATY
PH.D, Co-Founder Hakomi Institute of Israel
CHRISTIAN ANGERMAYER
Founder ATAI Life Sciences
Previous
Next

Partial PsyTech Summit Speaker List

BRUCE LINTON
Founder and Former Chairman & Co-CEO Canopy Growth Corporation
JR RAHN
Founder & Co-CEO Mindmed
FEATURED SPEAKER

RICK DOBLIN
Founder & Co-CEO Mindmed
KEREN TZARFATY
PH.D, Co-Founder Hakomi Institute of Israel
CHRISTIAN ANGERMAYER
Founder ATAI Life Sciences
DR. ROSALIND WATTS
Clinical Psychologist Psychedelic Research Group at Imperial College London
Previous
Next

The leading global Psychedelic Innovation Summit.

Apply now for the Psytech Live Pitch Event

PsyTech Summit is the global industry event for innovation in psychedelic medicine. With renewed research interest in LSD, MDMA, Ketamine and psilocybin, and a growing normalization after decades of stigma, psychedelics are quickly becoming the next therapeutic frontier.

Created by the team behind CannaTech, the PsyTech conference is poised to elevate the psychedelics conversation, foster normalization and accelerate innovation.

PsyTech debuts in Tel Aviv this June 14-15, and will bring together scientists, innovators, regulators, investors, and advocates from around the world to expand minds to the potential of psychedelic medicine.

The First-Ever global network for Psychedelic Medicine

Discover

Discover

Hear from experts: the researchers, doctors, and innovators who are conducting research into psychedelics and using the newest, most innovative therapies to treat mental health.

Connect

Connect

Find your niche among an international crowd of the industry’s deal makers and personalities. Become part of the first global network dedicated to innovation in psychedelic meds.

Accelerate

Accelerate

Psychedelics show tremendous potential for treating the most intractable mental illnesses. PsyTech is designed to accelerate innovation in the psychedelic space.

Invest

Invest

PsyTech Summit creates a global ecosystem of people dedicated to legalizing and normalizing psychedelics. Early-stage investors will leverage the community to source lucrative investment opportunities.

Psychedelic Medicine in the News

What the experts say about psychedelics

Rick Doblin

Founder of MAPS
“Psychedelics are not a substitute for faith. They are a door to authentic faith, born of encountering directly the sacred dimension of everyday experience. This is not the only gate to that discovery, but it is the most ancient and universal, and potentially the most accessible to the majority of the human race.”

Stanislav Grof

Pioneer in the field of Psychedelic Therapy

“In one of my early books I suggested that the potential significance of LSD and other psychedelics for psychiatry and psychology was comparable to the value the microscope has for biology or the telescope has for astronomy.”

Zach Haigney, The Trip Report

If DoubleBlind is your hot LA friend, The Trip Report is your friend who nags you about his Monday night standup open mic, Psymposia is your friend who makes sure you know how much privilege you have, Chacruna is your friend/grandmother who’s always right and tells it to you straight because she has a rare combination of your best interest at heart and matriarchal wisdom, then the Psychedelic Science Review is your super-smart friend who is shy with Midwestern reticence, a graduate science degree who can also hang out the bar.

SUBSCRIBE HERE to the psytech newsletter for investment opportunities, event invites & research updates:

Close Menu